- August 5, 2016 - VCS Seminar: Dr. Paul Rossman
- August 13-14, 2016 - Bone Marrow Workshop
- August 19, 2016 - VCS Seminar: Jordan J. Szymialis, Stuart & Branigin LLP
- August 26, 2016 - VCS Seminar: Dr. Ann Weil, Dr. Andrew Woolcock, and Dr. Jan Hawkins
- September 27 - October 1, 2016 - 2016 Purdue Veterinary Conference
“Rituximab and the Potential for Monoclonal Antibody Therapy for Canine Lymphoma”
Presenter: Dr. Paul Rossman, 2nd Year Resident, Oncology
Lymphoma is a common neoplasia seen in both people and dogs. While there are many forms of lymphoma in people, the more frequently encountered type is diffuse large B-cell lymphoma. Treatment involves systemic therapy, due to the disease being widespread throughout the body, and cytotoxic chemotherapy has served this role for decades. However, chemotherapy has reached its limit in regards to tumor response and survival benefit. Human medicine is now turning to targeted therapies which act synergistically with chemotherapy improving upon current benefits and potentially helping those who previously had a bleak prognosis. One such medication is rituximab, a monoclonal antibody directed against the B-cell surface protein CD20. This medication has significantly improved the outlook in patients with large B-cell lymphoma, particularly the elderly, and combination with chemotherapy is now considered standard of care. Similar to people, dogs have spontaneous forming lymphoma, of which the more common form is the diffuse large B-cell type. Chemotherapy has also been the mainstay of treatment for dog lymphoma but improved benefits to patients with chemotherapy alone is unlikely. This seminar will review the mechanisms behind monoclonal antibody therapy, development of monoclonal antibodies focusing on rituximab, and the benefits of rituximab treatment in people. Finally, we will discuss the development of monoclonal antibodies for dogs and where the veterinary community stands at this time. One (1) Continuing Education (CE) credit is offered for this seminar
This workshop is designed for professionals to review normal and pathologic bone marrow in companion animals via cytology and histology. Blood and bone marrow data from case examples will demonstrate correlation between the different biopsy methods. Learn through group discussions and personalized microscopy. Individual microscopes will be provided or bring your own. Trainees will gain confidence in evaluating bone marrow samples. Thirteen (13) Continuing Education (CE) units are available for this program.
Presenter: Jordan J. Szymialis, Stuart & Branigin LLP
Attorney Jordan J. Szymialis of Stuart & Branigin LLP will provide a presentation about legal issues that affect veterinarians and veterinary students. The presentation will conclude with
a question and answer session. ATTENTION: It is MANDATORY for all VCS residents, VTH interns, and DVM senior students to attend the Stuart & Branigin seminar.
“Bayer Communication Module”
Presenters: Dr. Ann Weil, Dr. Andrew Woolcock, and Dr. Jan Hawkins
ATTENTION: This is mandatory for all VCS residents and VTH interns, unless out of town. Please contact Dr. Woolcock to discuss any absence.
Purdue Veterinary Conference is designed to provide continuing education (CE) opportunities for the entire veterinary team. Attendees can earn up to 32 hours of CE. The 2016 Conference will offer new speakers, workshops and special events including a Veterinary Technology 40th Anniversary celebration.